AGP Executive Report
Last update: 8 hours agoAdolescent Mental Health: A European analysis links rising psychotropic drug use in teens to gender and economic parity, with girls in lower-parity countries seeing a wider gap and higher use. Pediatric Allergy Care: A Slovenia-led multicenter study reports that children with peanut allergy who had anaphylaxis show stronger skin test reactions, higher peanut-specific IgE, and more basophil activation—while lower responses were tied to later tolerance. Cancer Treatment Access: Cosylab and Heron Neutron Medical Corp. signed a Letter of Intent to expand global deployment of accelerator-based BNCT systems, aiming to speed software integration and clinical adoption. Rare Disease Drug Push: Ireland’s government is urged to move quickly on Friedreich’s Ataxia treatment access, with pressure to get the drug considered sooner. Slovenia Health Tech Funding: The EU Commission approved Slovenia’s sixth RRF payment request (€41m), including support for telemedicine upgrades and digital healthcare functions. Wellness & Nutrition Industry: TOSLA opened its Ajdovščina Super Factory (TOSLA 3), tripling liquid nutraceutical production capacity to up to 100,000 bottles per day. Youth Safety Online: Governments across Europe are moving toward stricter social media limits for minors, following Australia’s under-16 ban. Food Innovation: Revo Foods launched a mycelium-based whole-cut chicken fillet line in Austria, Germany, and Italy, positioning it as a high-fibre, minimally processed protein option.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.